Chicago private equity powerhouse Thoma Bravo is reaching across the Atlantic for its latest software trophy, striking a deal to take Kneat, an Irish maker of digital validation software for the life sciences industry, private in an all cash transaction. The agreement values Kneat at roughly C$650 million, about $466 million, and offers shareholders C$6.50 per share. If it goes through, the deal would pull the Limerick headquartered company off the Toronto Stock Exchange and tuck its platform into Thoma Bravo's growing software portfolio.
Kneat said its board and a special committee unanimously signed off on the Arrangement and that it plans to hold a shareholders' meeting by early August, with closing expected in the third quarter of 2026, subject to the usual shareholder and court approvals. The company added that the offer price works out to about a 40% premium to its share price before it kicked off a strategic review in May. Full details are laid out in the company announcement on GlobeNewswire.
As first reported by Crain's Chicago Business, the buyout was pegged in U.S. dollars at about $466 million. That local coverage followed Bloomberg's wider look at Thoma Bravo's current hunt for enterprise software assets.
What Kneat Does
Kneat builds a cloud platform that turns paper heavy validation and quality management workflows into digital ones for drug makers, device manufacturers and contract development organizations that have to hit strict regulatory standards. The business reported annual recurring revenue of $76.4 million as of March 31, 2026, along with record quarterly revenue in the first quarter of 2026, according to an investor update posted on Nasdaq.
Thoma Bravo's software playbook
Thoma Bravo has been a constant presence on the buy side of enterprise software deals, a strategy that Bloomberg says includes combing through lender books and secondary markets for opportunistic software targets. The firm itself points to hundreds of software transactions and a sizable investment footprint highlighted on Thoma Bravo.
What happens next
The Arrangement still needs shareholder approval and, where required, a nod from the Ontario Superior Court of Justice. If it gets those, Kneat expects to be delisted from the TSX and to stop filing public reports. The company says the transaction is not subject to a financing condition and is expected to close in the third quarter of 2026, assuming customary conditions and Court approval are met. A deeper dive into the approval process and related filings is available via GlobeNewswire.
For Kneat customers and employees, the near term message is steady as she goes, with the company saying it expects continuity of service and a focus on product investment, while investors walk away with an immediate cash premium. For Chicago deal watchers and software obsessives, the transaction lands as one more example of Thoma Bravo's push to roll up focused enterprise software businesses into larger platforms.
